Asthma's hidden switch: scientists hunt for calcium channels in Kids' immune cells
NCT ID NCT02809560
First seen Sep 21, 2026 ยท Last updated Sep 21, 2026
Summary
Researchers want to know whether certain calcium channels, called Cav1, appear on the immune cells of children with allergic asthma. These channels normally sit on nerve and muscle cells, but earlier animal work hinted they might also show up on the T cells that fuel asthma inflammation. The study collects sputum and blood samples from about 60 asthmatic children and compares them with samples from children without asthma. The goal is to see if Cav1 channels are present and whether they are more common in asthmatic children, which could point to a new treatment target.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- induced sputum collection using hypertonic saline
- What this could lead to
- If researchers find Cav1 channels on the immune cells that drive asthma, this could point toward new drugs that target those channels to calm airway inflammation.
- What could go wrong
- This is an early lab-based study with 60 children, so it may not confirm that Cav1 channels play a meaningful role in asthma. Even if it does, any treatment based on the finding would be years away.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Start date
-
Mar 2013
- Finished
-
May 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For Asthmatic children arm : * Girl not in childbearing potential or taking contraceptive treatment * Asthma diagnosis in at least 6 months as defined by clinical symptoms (expiratory dyspnea, wheezing, sibilance) and respiratory function (reversibility of VEMS at least 12% after salbutamol administration) * Allergologic tests positives to airborne allergens : positive prick test and/or specific IgE \> 0,35 kU/L for at least one allergen * Asthma severity between mild to moderate based on Global initiative for asthma classification during more than one month with inhaled corticotherapies +/- long term action beta -mimetic long compounds (salmeterol, formoterol) * Patient insured with a social security scheme For control children arm : * Girl not in childbearing potential or taking contraceptive treatment * No medical history of asthma * No medical history of allergy or symptoms of allergy on skin (atopic dermatitis), respiratory tract (rhino-conjunctivitis, asthma) or food allergy Exclusion Criteria: For both arms: * Chronic respiratory pathology : known occlusive or restrictive respiratory syndrome like interstitial lung disease, neuromuscular disease, mucoviscidoses, respiratory tract abnormalities with cough, dyspnea or digital hippocratism. * History of pulmonary or nose and throat infectious disease during last 4 months * Parasitic disease non treated during last 3 months * Dyspnea during the inclusion * Systemic corticotherapy during the last 3 months before inclusion * Immunosuppressive therapy during the last 3 months before inclusion * Diabeta * Disease causing immune disorder * Infection during inclusion * Participation to another study witch implies medical treatment during last 3 months before inclusion For asthmatic children arm : * Chronic pulmonary pathology (excluding asthma) * Asthma exacerbation during inclusion * VEMS \< 70% of normal range or VEMS \< 70% of normal range after inhalation of serum (despite salbutamol administration) * Patient unable to complete pulmonary function testing
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test cut asthma Flare-Ups?
- Breathing tests face off: can extra lung measurements improve asthma diagnosis?
- The carbon label on your inhaler: can it sway a Doctor's choice?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a digital program help teens with chronic illnesses move to adult care?
- Why do some kids catch every cold? a 1,200-Child study hunts for immune clues